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Case History 
 
A 35 year old woman presented to her local hospital with fever, night sweats 
and malaise.  Her initial investigations revealed anaemia (Hb 91g/L), 
hypercalcaemia (2.75mmol/L) and deranged liver function - bilirubin 38umol/l; 
ALT 424u/L, AST 402u/L,  ALP 1107u/L,   GGT 202u/L.  Viral (including HIV), 
TB (Quantiferon) and autoimmune screens were negative but serum 
angiotensin converting enzyme (ACE) levels were elevated (257 iU/L). A CT 
scan showed hepatosplenomegaly without lymphadenopathy or pulmonary 
nodules. Liver biopsy showed non-necrotising granulomas and on the basis of 
clinical, biochemical, radiological and histological features, a diagnosis of 
sarcoidosis was made.  
 
Her symptoms and biochemistry improved with Prednisolone, but relapsed on 
dose reduction. Azathioprine was introduced but discontinued due to 
pancytopenia. Bone marrow examination was normal.  Repeat CT abdomen 
showed massive splenomegaly. She underwent splenectomy, histology of 
which showed multiple non-necrotising granulomas with Acid-fast bacilli (AFB) 
seen on microscopy (samples were not sent for AFB culture). She was started 
on quadruple therapy for tuberculosis, but this was not tolerated (vomiting and 
worsening liver function). PCR from the splenectomy sample was negative for 
M tuberculosis and TB treatment was therefore stopped. Repeat liver biopsy 
again demonstrated granulomas with AFB on microscopy. Cultures grew a 
mycobacterium, identified as Mycobacterium intracellulare (MAI). This was 
considered a contaminant and she remained on Prednisolone for presumed 
sarcoidosis.   
 
She presented to our centre a year later, with persistent systemic upset and 
marked hepatomegaly. Reviewing her history, we noted previous mitral valve 
repair for acute mitral regurgitation secondary to chordae tendineae rupture in 
2014. In view of her surgical history, the possibility of disseminated 
Mycobacterium chimaera infection was considered. Subsequently, an 
echocardiogram showed a vegetation on the mitral valve (fig 1), and 
reassessment of the isolate previously identified as MAI confirmed its true 
identity as M chimaera.  
 
The patient was started on Rifabutin, Clarithromycin, Ethambutol and 
Amikacin. Amikacin was later substituted with Linezolid (because of hearing 
loss) which was replaced with Moxifloxacin (due to neuropathy). After 6 
months, her clinical symptoms and hepatomegaly have resolved, and liver 
function improved. The mitral valve vegetation persists and valve replacement 
is being considered.  
 
 
Discussion 
 
The presence of visible AFB in liver and spleen in the absence of a positive 
TB-PCR suggests disseminated non-tuberculous mycobacterial infection. The 
history of previous cardiac surgery raised the possibility of Mycobacteria 
chimaera infection. Similar cases of M chimaera infections acquired from 
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contaminated heating-cooler units used in cardiopulmonary bypass machines 
have been described since 20141-6.  M chimaera is very similar to MAI - only 
one base discriminates the two species on 16S rRNA sequencing - so 
misidentification is common1,2.  
 
Manifestations of M chimaera infection typically occur 3 months to 5 years 
after surgery and include endocarditis, wound or bone infection, 
splenomegaly, pancytopenia, hepatitis, renal involvement and embolic 
phenomena1,3-6. Treatment requires a prolonged course of combination 
therapy guided by macrolide sensitivity, typically Rifabutin, Clarithromycin, 
and Ethambutol with or without a quinolone or Amikacin4,5. Patients frequently 
need repeat surgical intervention. Death may occur despite prolonged 
antimicrobial therapy and mortality rates are high, up to 50%3-5.  
 
Differentiating a rare mycobacterial infection such as chimaera from 
sarcoidosis in the context of a multisystem granulomatous inflammation can 
be notoriously difficult. Features such as raised ACE levels and 
hypercalcaemia are non-specific and routine AFB culture techniques may be 
misleading1,2,4,6. Aggressive immunosuppression used for severe sarcoidosis 
may aggravate M chimaera infection4-6. Although action has been taken to 
limit newly acquired infections, it is likely that further M chimaera cases will 
emerge. Awareness of the association between a history of cardiopulmonary 
bypass and M chimaera acquisition is therefore crucial.  
 
 
Learning Point 
 
 
Mycobacterium chimaera was first identified as contaminating 
cardiopulmonary bypass equipment in 2014. Patients with previous cardiac 
surgery are at risk of having acquired this infection. Presenting symptoms and 
investigations may mimic other conditions including sarcoidosis. Awareness of 
the risk for Chimaera infection in this cohort of patients is therefore crucial.  
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 Figure 1: Echocardiogram showing a 2.2 x 1.5cm vegetation on the mitral 
valve 
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List of acronyms: 
 
ACE – angiotensin converting enzyme  
AFB – acid fast bacilli 
ALP – alkaline phosphatase 
ALT – alanine transaminase 
AST – aspartate aminotransferase 
CT – computed tomography 
GGT – gamma-glutamyl transferase 
Hb – Haemoglobin 
HIV – human immunodeficiency virus 
MAI – Mycobacterium avium intracellulare 
MTB – Mycobacterium tuberculosis 
PCR – polymerase chain reaction 
rRNA – ribosomal ribonucleic acid 
TB – Tuberculosis 
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